We only have this paper's title and publication details.
Read it at the sourcePhase II trial analysis demonstrates CAR-T cell responses to in vitro CD19 antigen stimulation in lymphoma patients, highlighting cell-intrinsic determinants of therapeutic efficacy.
Supplementary Figure S13. CAR-T response to in vitro CD19 antigen stimulation
No takes yet. Share an insight, caveat, or question.
Sarén et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: